HRMY
Harmony Biosciences Holdings
NASDAQ: HRMY · HEALTHCARE · BIOTECHNOLOGY
$31.26
+0.68% today
Updated 2026-04-30
Market cap
$1.80B
P/E ratio
11.46
P/S ratio
2.07x
EPS (TTM)
$2.71
Dividend yield
—
52W range
$26 – $41
Volume
1.0M
Harmony Biosciences Holdings (HRMY) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $89.28M | $106.70M | $427.07M | $433.44M | $673.87M | $811.45M | $999.20M |
| Cash & equivalents | $83.52M | $24.46M | $228.63M | $234.31M | $243.78M | $311.66M | $453.00M |
| Current assets | $86.68M | $31.50M | $262.89M | $284.44M | $400.29M | $451.07M | $579.25M |
| Total liabilities | $7.75M | $118.29M | $329.89M | $246.94M | $271.03M | $344.46M | $340.05M |
| Current liabilities | $7.23M | $19.89M | $134.54M | $53.77M | $78.88M | $163.78M | $175.08M |
| Long-term debt | — | $97.95M | $194.25M | $189.98M | $189.65M | $178.57M | $163.02M |
| Shareholder equity | $81.53M | $-11.59M | $97.18M | $186.51M | $402.84M | $466.99M | $659.15M |
| Retained earnings | $-242.67M | $-422.86M | $-488.19M | $-453.60M | $-272.13M | $-143.28M | $2.22M |
| Accounts receivable | $0.00 | $4.25M | $22.18M | $34.84M | $54.74M | $74.14M | $83.03M |
| Inventory | $0.00 | $1.09M | $3.82M | $4.43M | $4.30M | $5.36M | $7.20M |
| Goodwill | — | — | — | — | — | — | — |